# Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.

> **NCT07100093** · — · COMPLETED · sponsor: **Hospital Universitario La Paz** · enrollment: 100 (actual)

## Conditions studied

- Ustekinumab Serum Levels in Patients With Crohn´s Disease

## Interventions

- **PROCEDURE:** Drug serum levels

## Key facts

- **NCT ID:** NCT07100093
- **Lead sponsor:** Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-02-25
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07100093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07100093, "Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07100093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*